Sublingual edaravone dexborneol for the treatment of acute ischemic stroke: the TASTE-SL randomized clinical trial (vol 81, pg 319, 2024)

被引：0
|
作者：
Fu, Y.
Wang, A.
Tang, R.
机构：
来源：
JAMA NEUROLOGY | 2024年 / 81卷 / 04期
关键词：
D O I：
10.1001/jamaneurol.2024.0883
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：425 / 425
页数：1
相关论文
共 50 条
  • [1] Sublingual Edaravone Dexborneol for the Treatment of Acute Ischemic Stroke
    Fu, Yu
    Wang, Anxin
    Tang, Renhong
    Li, Shuya
    Tian, Xue
    Xia, Xue
    Ren, Jinsheng
    Yang, Shibao
    Chen, Rong
    Zhu, Shunwei
    Feng, Xiaofei
    Yao, Jinliang
    Wei, Yan
    Dong, Xueshuang
    Ling, Yun
    Yi, Fei
    Deng, Qian
    Guo, Cunju
    Sui, Yi
    Han, Shugen
    Wen, Guoqiang
    Li, Chuanling
    Dong, Aiqin
    Sun, Xin
    Wang, Zhimin
    Shi, Xueying
    Liu, Bo
    Fan, Dongsheng
    JAMA NEUROLOGY, 2024, : 319 - 326
  • [2] Safety And Efficacy Of Edaravone Dexborneol Versus Edaravone Alone For The Treatment Of Acute Ischemic Stroke Patients With Hypertention: Analysis From Taste Trial
    Xu, Jie
    Wang, Yongjun
    HYPERTENSION, 2021, 78
  • [3] Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study
    Shi, Fenghao
    He, Zixuan
    Wang, Lin
    Su, Hang
    Han, Sheng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [4] Effects of Tirofiban on Neurological Deterioration in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial (vol 81, pg 594, 2024)
    Zhao, W.
    Li, S.
    Li, C.
    JAMA NEUROLOGY, 2024,
  • [5] Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke A Phase III, Randomized, Double-Blind, Comparative Trial
    Xu, Jie
    Wang, Anxin
    Meng, Xia
    Yalkun, Gulbahram
    Xu, Anding
    Gao, Zhiqiang
    Chen, Huisheng
    Ji, Yong
    Xu, Jun
    Geng, Deqin
    Zhu, Runxiu
    Liu, Bo
    Dong, Aiqin
    Mu, Hua
    Lu, Zhihong
    Li, Shuya
    Zheng, Huaguang
    Chen, Xia
    Wang, Yilong
    Zhao, Xingquan
    Wang, Yongjun
    STROKE, 2021, 52 (03) : 772 - 780
  • [6] EDARAVONE DEXBORNEOL FOR THE TREATMENT OF ACUTE ISCHEMIC STROKE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Mortezaei, A.
    Rahmani, R.
    Emara, M.
    Sameer, O.
    Liebeskind, D.
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (02) : 186 - 186
  • [7] EFFICACY AND SAFETY OF EDARAVONE DEXBORNEOL FOR THE TREATMENT OF ACUTE ISCHEMIC STROKE UNDERGOING ENDOVASCULAR THROMBECTOMY (TASTE-2): A MULTICENTER, DOUBLE-BLIND, PLACEBOCONTROLLED, RANDOMIZED CLINICAL TRIAL
    Wang, C.
    Gu, H.
    Huo, X.
    Yuan, B.
    Li, S.
    Xu, J.
    Jiang, Y.
    Jing, J.
    Yao, X.
    Li, Z.
    Long, F.
    Ma, Z.
    Zhuang, X.
    Xu, L.
    Jin, Y.
    Huang, W.
    Zhang, Y.
    Wen, J.
    Wang, A.
    Pan, Y.
    Ye, W.
    Yu, W.
    Cheng, A.
    Wang, M.
    Dong, Q.
    Xu, A.
    Wang, N.
    Yang, Y.
    Meng, X.
    Liu, L.
    Zhao, X.
    Li, H.
    Miao, Z.
    Li, Z.
    Wang, Y.
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (02) : 58 - 58
  • [8] Rationale and design of Treatment of Acute Ischaemic Stroke with Edaravone Dexborneol II (TASTE-2): a multicentre randomised controlled trial
    Wang, Chunjuan
    Gu, Hong-Qiu
    Dong, Qiang
    Xu, Anding
    Wang, Ning
    Yang, Yi
    Wang, Feng
    Wang, Yongjun
    STROKE AND VASCULAR NEUROLOGY, 2024, 9 (06) : 730 - 737
  • [9] A randomized controlled clinical trial to compare the safety and efficacy of edaravone in acute ischemic stroke
    Sharma, Pawan
    Sinha, Manish
    Shukla, R.
    Garg, R. K.
    Verma, R.
    Singh, M. K.
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2011, 14 (02) : 103 - 106
  • [10] Combined Selective Endovascular Brain Hypothermia with Edaravone Dexborneol versus Edaravone Dexborneol Alone for Endovascular Treatment in Acute Ischemic Stroke (SHE): Protocol for a Multicenter, Single-Blind, Randomized Controlled Study
    Jiang, Xin
    Chen, Lizhang
    Wang, Jian
    Fang, Jinghuan
    Ma, Mengmeng
    Zhou, Muke
    Zheng, Hongbo
    Hu, Fayun
    Zhou, Dong
    He, Li
    CEREBROVASCULAR DISEASES, 2024,
12345